{
  "title": "A Fragile X Treatment May Be On The Horizon",
  "description": "Katie Clapp and Michael Tranfaglia's son was born with a genetic disorder that affects brain development. It makes it hard to learn language and basic daily tasks and often is accompanied by a host of other disorders.  To help find a cure, they started a foundation and raised research money.  After several setbacks, one treatment is showing promise.  NPR neuroscience reporter Jon Hamilton tells Emily Kwong the story.",
  "pubDate": "Thu, 06 May 2021 04:10:22 -0400",
  "copyright": "Copyright 2019-2021 NPR - For Personal Use Only",
  "guid": "cda02829-3f24-42a8-9608-851ad1859d80",
  "link": "https://www.npr.org/2021/05/05/993838102/a-fragile-x-treatment-may-be-on-the-horizon",
  "itunes:title": "A Fragile X Treatment May Be On The Horizon",
  "itunes:author": "NPR",
  "itunes:summary": "Katie Clapp and Michael Tranfaglia's son was born with a genetic disorder that affects brain development. It makes it hard to learn language and basic daily tasks and often is accompanied by a host of other disorders.  To help find a cure, they started a foundation and raised research money.  After several setbacks, one treatment is showing promise.  NPR neuroscience reporter Jon Hamilton tells Emily Kwong the story.",
  "itunes:image": "",
  "itunes:duration": 684,
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "content:encoded": "Katie Clapp and Michael Tranfaglia's son was born with a genetic disorder that affects brain development. It makes it hard to learn language and basic daily tasks and often is accompanied by a host of other disorders.  To help find a cure, they started a foundation and raised research money.  After several setbacks, one treatment is showing promise.  NPR neuroscience reporter Jon Hamilton tells Emily Kwong the story.",
  "enclosure": ""
}